title: [Status epilepticus in MVEC chemotherapy of urothelial cancer].
abstract: We present a patient with an urethral urethelial carcinoma (T3N2M0) treated by chemotherapy with methotrexate, vinblastine, epirubicin and cisplatin, which induced a non-convulsive status epilepticus. In this report the possible mechanism for this phenomenon and its management are discussed.
authors.affiliation: Urologische Klinik, Rheinischen Friedrich-Wilhelms-Universität Bonn.
authors.forename: S
authors.initials: S
authors.lastname: Meessen
authors.forename: R R
authors.initials: RR
authors.lastname: Riedel
authors.forename: P
authors.initials: P
authors.lastname: Brühl
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000097:blood / Q000188:drug therapy*; D004569:Electroencephalography / Q000187:drug effects; D006801:Humans; D008297:Male; D010672:Phenytoin / Q000493:pharmacokinetics / Q000627:therapeutic use; D013226:Status Epilepticus / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D014523:Urethral Neoplasms / Q000097:blood / Q000188:drug therapy*
chemical_list: D010672:Phenytoin
vernacular_title: Status epilepticus unter MVEC-Chemotherapie eines Urothelkarzinoms.